2011
DOI: 10.1016/j.vaccine.2011.04.067
|View full text |Cite
|
Sign up to set email alerts
|

Influenza vaccine coverage, influenza-associated morbidity and all-cause mortality in Catalonia (Spain)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Differences in the magnitude of estimates from the two methods will be not only because they include bronchitis deaths but also because the rate difference-type method used by Fleming and colleagues tends to produce higher estimates of excess than the Serfling-type method we used, due to a lower reference mortality and the mortality rate in the ‘influenza-active periods’ being entirely attributed to influenza 55. There has been much interest in measuring the impact of influenza vaccination campaigns in other settings 14 15 17 56. Excess all-cause mortality declined in the Dutch elderly after the introduction of universal yearly vaccination of those aged 65 years and over, which saw yearly coverage reach 80% 14.…”
Section: Discussionmentioning
confidence: 98%
“…Differences in the magnitude of estimates from the two methods will be not only because they include bronchitis deaths but also because the rate difference-type method used by Fleming and colleagues tends to produce higher estimates of excess than the Serfling-type method we used, due to a lower reference mortality and the mortality rate in the ‘influenza-active periods’ being entirely attributed to influenza 55. There has been much interest in measuring the impact of influenza vaccination campaigns in other settings 14 15 17 56. Excess all-cause mortality declined in the Dutch elderly after the introduction of universal yearly vaccination of those aged 65 years and over, which saw yearly coverage reach 80% 14.…”
Section: Discussionmentioning
confidence: 98%
“…The efficacy and effectiveness of influenza vaccination for multiple possible outcome measures, including the prevention of medically attended acute respiratory illness, prevention of laboratory-confirmed influenza, prevention of influenza- or pneumonia-associated hospitalizations or deaths, and prevention of seroconversion to circulating influenza virus strains, has been assessed in clinical trials and observational studies in different populations. 1 , 2 , 4 - 6 In a recent meta-analysis, Osterholm et al 2 found that influenza vaccines can provide moderate protection against virologically confirmed influenza, but that such protection is greatly reduced or absent in some seasons. Even so, current influenza vaccines will continue to play a role in reducing the morbidity of influenza until more effective interventions are available.…”
Section: Introductionmentioning
confidence: 99%
“…This function was used to identify trend changes over the study period; SC show specific four-week periods when the incidence of whooping cough changed its previous behaviour (increases or decreases) [21]. …”
Section: Methodsmentioning
confidence: 99%